TXMD — TherapeuticsMD Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for TherapeuticsMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	80.5	64.9	38.1	4.33	5.06
Net Total Accounts Receivable
Net Total Receivables	32.4	—	—	3.09	3.56
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	128	119	55.4	11.8	12.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	11.5	9.06	7.66	6.87	6.1
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	182	169	90.5	43.3	38.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	59.2	253	46.8	6.85	5.17
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	306	263	55.3	14	11.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-124	-93.6	35.1	29.3	27.4
Total Liabilities & Shareholders' Equity	182	169	90.5	43.3	38.8
Total Common Shares Outstanding